The takeover gives J&J control of software designed to standardize operations by providing teams with a checklist of best practices.

Here's Wednesday's medtech news of note.

OptiScan Biomedical scored an FDA nod for its bedside device that continuously monitors ICU patients’ glucose levels.

Episona, which launched its epigenetic test in fertility clinics last October, is now offering it online.

The deal connects Ionis to the manufacturer of a blood collection device that could simplify mitigation of its drugs’ safety risks.

ReWalk Robotics is gearing up for the clinical testing of its soft suit exoskeleton, which it plans to launch next year.

Boston Scientific forked over $175 million up front for Apama Medical, which is working on a new treatment for afib.

Illumina Ventures reeled in $130 million in new funding, bringing its genomics-ventured fund to $230 million.

The green light marks the arrival of a rare new entrant to the field of abdominal surgery robotics.

Here's Friday's medtech news of note.